TNFSF11 and osteoporosis: The current osteoporosis treatments include administration of drugs that inhibit bone resorption and promote bone formation [137,138,139,140]; the drugs that inhibit bone resorption include SERM, bisphosphonates, and denosumab, an anti-RANKL antibody.